<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940705-2-00207</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix I&hyph;III&hyph;K. Blattner, F.R., B.G. Williams, A.E. Bleche, K.  <!-- PJG 0012 frnewline --> Denniston-Thompson, H.E. Faber, L.A. Furlong, D.J. Gunwald, D.O. Kiefer, D.D. Moore, J.W. Shumm, E.L. Sheldon, and O. Smithies, Charon Phages: Safer  <!-- PJG 0012 frnewline --> Derivatives of Bacteriophage Lambda for DNA Cloning, Science 1977, 196, pp.  <!-- PJG 0012 frnewline --> 163&hyph;169.  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;L. Donoghue, D.J., and P.A. Sharp, An Improved Lambda Vector:  <!-- PJG 0012 frnewline --> Construction of Model Recombinants Coding for Kanamycin Resistance, Gene, 1977, 1,  <!-- PJG 0012 frnewline --> pp. 209&hyph;227.  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;M. Leder, P., D. Tiemeier and L. Enquist (1977), EK2 Derivatives of  <!-- PJG 0012 frnewline --> Bacteriophage Lambda Useful in the Cloning of DNA from Higher Organisms: The  <!-- PJG 0012 frnewline -->  <!-- PJG 0037 unknown --> gt WES System, Science, 1977, 196, pp. 175&hyph;177.  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;N. Skalka, A., Current Status of Coliphage AEK2 Vectors, Gene, 1978,  <!-- PJG 0012 frnewline --> 3, pp. 29&hyph;35.  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;O. Szybalski, W., A. Skalka, S. Gottesman, A. Campbell, and D.  <!-- PJG 0012 frnewline --> Botstein, Standardized Laboratory Tests for EK2 Certification, Gene, 1978, 3, pp.  <!-- PJG 0012 frnewline --> 36&hyph;38.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Appendix J. Biotechnology Research Subcommittee  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The National Science and Technology Council's Committee on Fundamental  <!-- PJG 0012 frnewline --> Science determined that a subcommittee should be continued to identify and  <!-- PJG 0012 frnewline --> coordinate Federal research efforts, identify research needs, stimulating  <!-- PJG 0012 frnewline --> international cooperation, and assess national and international policy issues  <!-- PJG 0012 frnewline --> concerning biotechnology sciences. The primary emphasis will be on scientific issues  <!-- PJG 0012 frnewline --> to increase the overall effectiveness and productivity of the Federal investment in  <!-- PJG 0012 frnewline --> biotechnology sciences, especially regarding issues which cut across agency  <!-- PJG 0012 frnewline --> boundaries. This subcommittee is called the Biotechnology Research Subcommittee.  <!-- PJG 0012 frnewline --> Membership of the Biotechnology Research Subcommittee will include Federal  <!-- PJG 0012 frnewline --> agencies that support biotechnology research. Agencies represented are: U.S.  <!-- PJG 0012 frnewline --> Department of Agriculture, Department of Commerce, Department of Defense,  <!-- PJG 0012 frnewline --> Department of Energy, Department of Health and Human Services, Department of  <!-- PJG 0012 frnewline --> Interior, Department of Justice, Department of State, Department of Veterans  <!-- PJG 0012 frnewline --> Affairs, Agency for International Development, Environmental Protection Agency,  <!-- PJG 0012 frnewline --> National Aeronautics and Space Administration, and National Science Foundation.  <!-- PJG 0012 frnewline --> The Biotechnology Research Subcommittee will function in an advisory capacity to  <!-- PJG 0012 frnewline --> the Committee on Fundamental Science, the Director of the Office of Science and  <!-- PJG 0012 frnewline --> Technology Policy, and the Executive Office of the President. The Biotechnology  <!-- PJG 0012 frnewline --> Research Subcommittee will review the scientific aspects of proposed regulations  <!-- PJG 0012 frnewline --> and guidelines as they are developed.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            